MPST
Basic information
Region (hg38): 22:37019635-37029821
Links
Phenotypes
GenCC
Source:
- encephalopathy due to beta-mercaptolactate-cysteine disulfiduria (No Known Disease Relationship), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MPST gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 24 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 1 | 0 |
Variants in MPST
This is a list of pathogenic ClinVar variants found in the MPST region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-37019867-A-G | not specified | Uncertain significance (Oct 14, 2023) | ||
22-37024226-C-T | not specified | Uncertain significance (May 24, 2023) | ||
22-37024253-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
22-37024255-C-A | not specified | Uncertain significance (Jan 31, 2022) | ||
22-37024257-A-C | not specified | Uncertain significance (May 28, 2024) | ||
22-37024304-A-C | not specified | Uncertain significance (Jan 04, 2024) | ||
22-37024363-G-C | not specified | Uncertain significance (Oct 12, 2021) | ||
22-37024370-G-A | not specified | Uncertain significance (Oct 18, 2021) | ||
22-37024382-G-T | MPST-related disorder | Likely benign (Jan 12, 2023) | ||
22-37024417-C-A | not specified | Uncertain significance (Dec 15, 2022) | ||
22-37024433-A-T | not specified | Uncertain significance (Aug 12, 2021) | ||
22-37024463-C-A | not specified | Uncertain significance (Jan 02, 2024) | ||
22-37024469-A-G | Encephalopathy due to beta-mercaptolactate-cysteine disulfiduria | not provided (-) | ||
22-37024484-G-C | not specified | Uncertain significance (Jun 06, 2023) | ||
22-37024544-C-T | not specified | Uncertain significance (Jan 26, 2023) | ||
22-37024552-G-A | not specified | Uncertain significance (May 17, 2023) | ||
22-37024612-C-A | not specified | Uncertain significance (Jun 03, 2022) | ||
22-37024625-G-A | not specified | Uncertain significance (Jun 22, 2024) | ||
22-37024674-G-C | not specified | Uncertain significance (Jan 20, 2023) | ||
22-37024784-G-A | not specified | Uncertain significance (Sep 15, 2021) | ||
22-37024790-C-T | not specified | Uncertain significance (Jun 05, 2024) | ||
22-37029236-C-A | not specified | Uncertain significance (Dec 08, 2022) | ||
22-37029245-G-C | not specified | Uncertain significance (Dec 08, 2023) | ||
22-37029291-A-G | not specified | Uncertain significance (Dec 20, 2023) | ||
22-37029323-G-A | not specified | Uncertain significance (May 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MPST | protein_coding | protein_coding | ENST00000397129 | 3 | 10188 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000347 | 0.603 | 125688 | 0 | 24 | 125712 | 0.0000955 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.21 | 153 | 201 | 0.760 | 0.0000147 | 1983 |
Missense in Polyphen | 40 | 56.56 | 0.70721 | 610 | ||
Synonymous | 2.28 | 69 | 97.6 | 0.707 | 0.00000831 | 654 |
Loss of Function | 0.769 | 8 | 10.7 | 0.746 | 6.99e-7 | 106 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000148 | 0.000148 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000590 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000134 | 0.000123 |
Middle Eastern | 0.0000590 | 0.0000544 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.000173 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Transfer of a sulfur ion to cyanide or to other thiol compounds. Also has weak rhodanese activity. Detoxifies cyanide and is required for thiosulfate biosynthesis. Acts as an antioxidant. In combination with cysteine aminotransferase (CAT), contributes to the catabolism of cysteine and is an important producer of hydrogen sulfide in the brain, retina and vascular endothelial cells. Hydrogen sulfide H(2)S is an important synaptic modulator, signaling molecule, smooth muscle contractor and neuroprotectant. Its production by the 3MST/CAT pathway is regulated by calcium ions. {ECO:0000250|UniProtKB:P97532}.;
- Disease
- DISEASE: Note=Aberrant MPST activity is found in a few cases of mercaptolactate-cysteine disulfiduria (MCDU) characterized by the appearance of large quantaties of the sulfur-containing amino acid, beta-mercaptolactate-cysteine disulfide, in the urine (PubMed:4973015, PubMed:4690911 and PubMed:6945862). Some cases have associated mental retardation (PubMed:4973015 and PubMed:6945862).;
- Pathway
- Sulfur relay system - Homo sapiens (human);Cysteine and methionine metabolism - Homo sapiens (human);Sulfur metabolism - Homo sapiens (human);Beta-mercaptolactate-cysteine disulfiduria;Cysteine Metabolism;Cystinosis, ocular nonnephropathic;Trans-sulfuration pathway;Amino Acid metabolism;Degradation of cysteine and homocysteine;Metabolism of amino acids and derivatives;L-cysteine degradation II;Metabolism;Methionine Cysteine metabolism;Methionine and cysteine metabolism;Sulfur amino acid metabolism
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.0827
- hipred
- N
- hipred_score
- 0.339
- ghis
- 0.447
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.749
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mpst
- Phenotype
- reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- sulfur amino acid catabolic process;kidney development;liver development;cyanate catabolic process;response to toxic substance;transsulfuration;spinal cord development;hydrogen sulfide biosynthetic process
- Cellular component
- mitochondrial matrix;cytosol;cell junction;neuron projection;synapse;extracellular exosome
- Molecular function
- thiosulfate sulfurtransferase activity;3-mercaptopyruvate sulfurtransferase activity;identical protein binding